Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Notch3 gene amplification in ovarian cancer.

Park JT, Li M, Nakayama K, Mao TL, Davidson B, Zhang Z, Kurman RJ, Eberhart CG, Shih IeM, Wang TL.

Cancer Res. 2006 Jun 15;66(12):6312-8.

2.

Amplicon profiles in ovarian serous carcinomas.

Nakayama K, Nakayama N, Jinawath N, Salani R, Kurman RJ, Shih IeM, Wang TL.

Int J Cancer. 2007 Jun 15;120(12):2613-7.

3.

Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes.

Yeasmin S, Nakayama K, Rahman MT, Rahman M, Ishikawa M, Iida K, Otsuki Y, Kobayashi H, Nakayama S, Miyazaki K.

Gynecol Oncol. 2010 Jun;117(3):409-16. doi: 10.1016/j.ygyno.2010.03.004. Epub 2010 Mar 31.

PMID:
20359736
4.

Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.

Shih IeM, Nakayama K, Wu G, Nakayama N, Zhang J, Wang TL.

Mod Pathol. 2011 May;24(5):638-45. doi: 10.1038/modpathol.2010.230. Epub 2011 Jan 14.

5.

Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer.

Rahman MT, Nakayama K, Rahman M, Katagiri H, Katagiri A, Ishibashi T, Ishikawa M, Iida K, Nakayama S, Otsuki Y, Miyazaki K.

Am J Clin Pathol. 2012 Oct;138(4):535-44.

PMID:
23010708
6.

Identification of Pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.

Park JT, Shih IeM, Wang TL.

Cancer Res. 2008 Nov 1;68(21):8852-60. doi: 10.1158/0008-5472.CAN-08-0517.

7.

Defining NOTCH3 target genes in ovarian cancer.

Chen X, Thiaville MM, Chen L, Stoeck A, Xuan J, Gao M, Shih IeM, Wang TL.

Cancer Res. 2012 May 1;72(9):2294-303. doi: 10.1158/0008-5472.CAN-11-2181. Epub 2012 Mar 6.

8.

Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.

Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA, Chia S, Magliocco A, Makretsov N, Gilks B, Pollack J, Huntsman D.

Gynecol Oncol. 2006 Feb;100(2):264-70. Epub 2005 Oct 19.

PMID:
16236351
9.

Functional analysis of genes in regions commonly amplified in high-grade serous and endometrioid ovarian cancer.

Davis SJ, Sheppard KE, Pearson RB, Campbell IG, Gorringe KL, Simpson KJ.

Clin Cancer Res. 2013 Mar 15;19(6):1411-21. doi: 10.1158/1078-0432.CCR-12-3433. Epub 2013 Jan 29.

10.

Notch3 pathway alterations in ovarian cancer.

Hu W, Liu T, Ivan C, Sun Y, Huang J, Mangala LS, Miyake T, Dalton HJ, Pradeep S, Rupaimoole R, Previs RA, Han HD, Bottsford-Miller J, Zand B, Kang Y, Pecot CV, Nick AM, Wu SY, Lee JS, Sehgal V, Ram P, Liu J, Tucker SL, Lopez-Berestein G, Baggerly KA, Coleman RL, Sood AK.

Cancer Res. 2014 Jun 15;74(12):3282-93. doi: 10.1158/0008-5472.CAN-13-2066. Epub 2014 Apr 17.

11.

Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.

Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC.

Cancer Genet Cytogenet. 2004 Dec;155(2):97-107.

PMID:
15571795
12.

Notch3 interactome analysis identified WWP2 as a negative regulator of Notch3 signaling in ovarian cancer.

Jung JG, Stoeck A, Guan B, Wu RC, Zhu H, Blackshaw S, Shih IeM, Wang TL.

PLoS Genet. 2014 Oct 30;10(10):e1004751. doi: 10.1371/journal.pgen.1004751. eCollection 2014 Oct.

13.

Notch3 overexpression is related to the recurrence of ovarian cancer and confers resistance to carboplatin.

Park JT, Chen X, Tropè CG, Davidson B, Shih IeM, Wang TL.

Am J Pathol. 2010 Sep;177(3):1087-94. doi: 10.2353/ajpath.2010.100316. Epub 2010 Jul 29.

14.

Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.

Birrer MJ, Johnson ME, Hao K, Wong KK, Park DC, Bell A, Welch WR, Berkowitz RS, Mok SC.

J Clin Oncol. 2007 Jun 1;25(16):2281-7. Erratum in: J Clin Oncol. 2007 Jul 20;25(21):3184.

PMID:
17538174
15.

Amplification of 11q13 in ovarian carcinoma.

Brown LA, Kalloger SE, Miller MA, Shih IeM, McKinney SE, Santos JL, Swenerton K, Spellman PT, Gray J, Gilks CB, Huntsman DG.

Genes Chromosomes Cancer. 2008 Jun;47(6):481-9. doi: 10.1002/gcc.20549.

PMID:
18314909
16.

New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.

Lopez-Gines C, Gil-Benso R, Ferrer-Luna R, Benito R, Serna E, Gonzalez-Darder J, Quilis V, Monleon D, Celda B, Cerdá-Nicolas M.

Mod Pathol. 2010 Jun;23(6):856-65. doi: 10.1038/modpathol.2010.62. Epub 2010 Mar 19.

17.

Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas.

Etemadmoghadam D, deFazio A, Beroukhim R, Mermel C, George J, Getz G, Tothill R, Okamoto A, Raeder MB, Harnett P, Lade S, Akslen LA, Tinker AV, Locandro B, Alsop K, Chiew YE, Traficante N, Fereday S, Johnson D, Fox S, Sellers W, Urashima M, Salvesen HB, Meyerson M, Bowtell D; AOCS Study Group.

Clin Cancer Res. 2009 Feb 15;15(4):1417-27. doi: 10.1158/1078-0432.CCR-08-1564. Epub 2009 Feb 3.

18.

Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes.

Noske A, Henricksen LA, LaFleur B, Zimmermann AK, Tubbs A, Singh S, Storz M, Fink D, Moch H.

Exp Mol Pathol. 2015 Feb;98(1):47-54. doi: 10.1016/j.yexmp.2014.12.004. Epub 2014 Dec 16.

PMID:
25527175
19.

A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19.

Sung CO, Song IH, Sohn I.

Gynecol Oncol. 2014 Feb;132(2):343-50. doi: 10.1016/j.ygyno.2013.11.036. Epub 2013 Dec 8.

PMID:
24321399
20.

NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.

Yamaguchi N, Oyama T, Ito E, Satoh H, Azuma S, Hayashi M, Shimizu K, Honma R, Yanagisawa Y, Nishikawa A, Kawamura M, Imai J, Ohwada S, Tatsuta K, Inoue J, Semba K, Watanabe S.

Cancer Res. 2008 Mar 15;68(6):1881-8. doi: 10.1158/0008-5472.CAN-07-1597.

Supplemental Content

Support Center